MDS Virtual Congress 2021 Archives - Page 92 of 132

Physical activity and cognitive functions in individuals with Parkinson’s disease

APC. Loureiro, VL. Israel, B. Yamaguchi (Curitiba, Brazil)
Physical activity and subjective perception of PD symptoms during COVID-19 lockdown: a clinical audit

V. Foster, J. Pasquini, N. Pavese (Newcastle Upon Tyne, United Kingdom)
PHYSICAL ACTIVITY AT HOME IS ABLE TO REDUCE THE WORSENING IN QUALITY OF LIFE IN PARKINSON’S DISEASE DURING COVID-19 PANDEMIC

I. Nascimento, C. Batista, D. Coelho, L. Almeida, A. Guimarães, A. Lindquist, V. Israel, H. Kanegusuku, R. Guimarães, N. Bosaipo, R. Barbosa, C. Correa, M. Finatto, F. Mendes, R. Azamor, M. Piemonte (São Paulo, Brazil)
Physical and mental fatigue in Parkinson’s Disease: analysis from COPPADIS database

MI. Morales-Casado, N. López-Ariztegui, A. Oliviero, V. Soto-León, JC. Segundo-Rodríguez, T. Deus Fonticoba, S. Jesús, M. Aguilar, P. Pastor, LL. Planellas, M. Cosgaya, J. García-Caldentey, N. Caballol, B. Vives, J. Hernández-Vara, I. Cabo, L. López-Manzanares, I. González-Aramburu, MA. ávila-Rivera, MJ. Catalán, V. Nogueira, V. Puente, M. Ruíz-de Arcos, C. Borrué, B. Solano-Vila, M. álvarez-Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo-Padilla, JC. Martínez-Castrillo, P. Sánchez-Alonso, MG. Alonso-Losada, P. Clavero, J. Kulisevsky, M. Blázquez-Estrada, M. Seijo, J. Ruíz-Martinez, C. Valero, M. Kurtis, O. de Fábregues, J. González-Ardura, C. Ordás, L. López-Díaz, P. Mir, P. Martínez-Martín, D. Santos-García, C. Study Group (Toledo, Spain)
Piecing Together the Gut Microbiome in Parkinson’s Disease: A Meta-Analysis

TS. Toh, CW. Chong, SY. Lim, AH. Tan (Kuala Lumpur, Malaysia)
Pilot study of Phenotype of Antisense-Oligonucleotide-(ASO)-knockdown of Cerebral-Dopamine-Neurotrophic-Factor (CDNF) as Parkinson Disease model : implications for PD and related Dementia Therapeutics

SS. Chiu, K. Terpstra, RK. Mishra (London, Canada)
Pilot study to assess gait-related motor symptoms in Parkinson’s disease by using a unique passive monitoring wearable technology

G. Monneret, D. Jacobs, L. Farid, A. Post, C. Moreau, G. Baille (Paris, France)
Pilot study to evaluate pimavanserin for the treatment of motor and behavioral symptoms of Tourette syndrome.

A. Billnitzer, J. Jankovic (Houston, USA)
PKG for the management of advance Parkinson’s Disease

S. Duja (Dudley, United Kingdom)
PLA2G6-Associated Neurodegeneration: A Continuum of Phenotypes

D. Shah-Zamora, M. Bailey (Chicago, USA)